他汀类药物对有氧运动训练后脂肪氧化改善的影响
该研究纳入106例代谢综合征患者,分为长期服用他汀组(n=46)和他汀未用药对照组(n=60),完成16周监督下高强度间歇训练。结果显示,他汀组训练前最大脂肪氧化率较低,但训练后两组最大脂肪氧化率改善程度相似;结论认为长期他汀治疗与训练前运动脂肪氧化减弱相关,但不削弱有氧运动训练带来的脂肪氧化改善。
要点
- 他汀组训练前最大脂肪氧化率低于对照组(0.19±0.08 vs 0.23±0.07 g·min⁻¹,P=0.023)。
- 训练后两组最大脂肪氧化率改善相似(他汀组0.06±0.08,95%CI 0.03-0.08;对照组0.05±0.09,95%CI 0.03-0.07 g·min⁻¹,P<0.001)。
- 训练后他汀组最大脂肪氧化率出现的工作负荷较对照组低28%(38±26 vs 53±32 W,P=0.048)。
核心结论
- 长期他汀治疗与训练前运动脂肪氧化减弱相关,但他汀使用不削弱高强度有氧运动训练带来的最大脂肪氧化率改善。
研究设计与样本
- 研究纳入106例代谢综合征个体,长期服用他汀者(他汀组,n=46)与他汀未用药者(对照组,n=60)完成16周监督下高强度间歇训练。
- 训练前后隔夜空腹状态下评估最大摄氧量、最大脂肪氧化率及工作负荷-脂肪氧化曲线形状。
主要发现
- 两组基线最大摄氧量相似,训练后均升高,但对照组升高幅度大于他汀组(19.4% vs 12.6%,P=0.013)。
- 训练前他汀组最大脂肪氧化率低于对照组(0.19±0.08 vs 0.23±0.07 g·min⁻¹,P=0.023),且出现于较低工作负荷(33±21 vs 37±19 W,P=0.015)。
- 训练后两组最大脂肪氧化率改善相似(他汀组0.06±0.08,95%CI 0.03-0.08 g·min⁻¹;对照组0.05±0.09,95%CI 0.03-0.07 g·min⁻¹;P<0.001)。
- 训练后他汀组最大脂肪氧化率出现的工作负荷较对照组低28%(38±26 vs 53±32 W,P=0.048)。
- 训练后两组摄氧量-工作负荷斜率均下降(均P<0.001),呼吸交换率-工作负荷斜率亦降低;无论是否使用他汀,训练后所有工作负荷下脂肪氧化均增加。
临床怎么用
- 作者认为该发现应鼓励他汀使用者进行运动训练,以便在体能改善后获益于脂肪氧化增加。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
CONTEXT: Statins blunt cardiorespiratory fitness improvements after exercise training and may affect fat oxidation adaptations to training. OBJECTIVE: To determine if long-term statin use in dyslipidemic individuals restricts the improvements in fat oxidation typically observed after an intense exercise-training program. METHODS: A total of 106 metabolic syndrome individuals either chronically medicated with statins (ie, statin group; n = 46) or statin naive (ie, control group; n = 60) completed a 16-week supervised high-intensity interval training program. Maximal rates of oxygen consumption (V˙O2MAX), fat oxidation (FOMAX), and the shape of the workload-fat oxidation curve were assessed before and 48 hours after training in an overnight fasted state. RESULTS: Starting from a similar value at baseline, both groups increased V˙O2MAX after training, but the increase was larger in the control than in the statin group (19.4% vs 12.6%; P = .013). Before training, FOMAX in the statin group was lower (0.19 ± 0.08 vs 0.23 ± 0.07 g·min-1; P = .023) and took place at a lower workload (33 ± 21 vs 37 ± 19 W; P = .015) than in the control group. After training, FOMAX improved similarly in both groups (0.06 ± 0.08; 95% CI, 0.03-0.08 g·min-1 and 0.05 ± 0.09; 95% CI, 0.03-0.07 g·min-1, for statin and control groups, respectively; (P < .001). Still, after training, FOMAX occurred at a 28% lower workload in the statin group (38 ± 26 vs 53 ± 32 W; P = .048). The V˙O2-workload slope decreased after training in both groups (both P < .001) along with reductions in the respiratory exchange ratio-workload slope. Fat oxidation increased at all workloads after training regardless of the use of statins. CONCLUSION: Long-term statin treatment is associated with blunted exercise fat oxidation before exercise training. However, statin use does not attenuate the improvements in exercise fat oxidation (FOMAX) derived from intense aerobic exercise training. This finding should encourage statin users to exercise-train to benefit from increased fat oxidation once their fitness level improves.
引用
- Alvarez-Jimenez L, Morales-Palomo F, Moreno-Cabañas A, et al. Effects of Statins on Fat Oxidation Improvements After Aerobic Exercise Training. J Clin Endocrinol Metab. 2023. PMID: 36394519. doi:10.1210/clinem/dgac668
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。